Becton Dickinson EBIT 2012-2026 | BDX
Becton Dickinson annual and quarterly EBIT history from 2012 to 2026. EBIT can be defined as earnings before interest and taxes.
- Becton Dickinson EBIT for the quarter ending March 31, 2026 was $93M, a 83% decline year-over-year.
- Becton Dickinson EBIT for the twelve months ending March 31, 2026 was $2.221B, a 0.27% decline year-over-year.
- Becton Dickinson 2025 annual EBIT was $2.578B, a 7.51% increase from 2024.
- Becton Dickinson 2024 annual EBIT was $2.398B, a 13.6% increase from 2023.
- Becton Dickinson 2023 annual EBIT was $2.111B, a 7.53% decline from 2022.
|
Becton Dickinson Annual EBIT (Millions of US $) |
|
|---|---|
| 2025 | $2,578 |
| 2024 | $2,398 |
| 2023 | $2,111 |
| 2022 | $2,283 |
| 2021 | $2,251 |
| 2020 | $912 |
| 2019 | $1,760 |
| 2018 | $1,509 |
| 2017 | $1,522 |
| 2016 | $1,430 |
| 2015 | $1,074 |
| 2014 | $1,606 |
| 2013 | $1,255 |
| 2012 | $1,558 |
| 2011 | $1,665 |
|
Becton Dickinson Quarterly EBIT (Millions of US $) |
|
|---|---|
| 2026-03-31 | $93 |
| 2025-12-31 | $551 |
| 2025-09-30 | $695 |
| 2025-06-30 | $882 |
| 2025-03-31 | $547 |
| 2024-12-31 | $454 |
| 2024-09-30 | $624 |
| 2024-06-30 | $602 |
| 2024-03-31 | $734 |
| 2023-12-31 | $438 |
| 2023-09-30 | $351 |
| 2023-06-30 | $547 |
| 2023-03-31 | $627 |
| 2022-12-31 | $586 |
| 2022-09-30 | $489 |
| 2022-06-30 | $537 |
| 2022-03-31 | $566 |
| 2021-12-31 | $691 |
| 2021-09-30 | $84 |
| 2021-06-30 | $492 |
| 2021-03-31 | $433 |
| 2020-12-31 | $1,242 |
| 2020-09-30 | $-317 |
| 2020-06-30 | $359 |
| 2020-03-31 | $369 |
| 2019-12-31 | $501 |
| 2019-09-30 | $112 |
| 2019-06-30 | $626 |
| 2019-03-31 | $136 |
| 2018-12-31 | $886 |
| 2018-09-30 | $576 |
| 2018-06-30 | $511 |
| 2018-03-31 | $187 |
| 2017-12-31 | $235 |
| 2017-09-30 | $491 |
| 2017-06-30 | $-224 |
| 2017-03-31 | $445 |
| 2016-12-31 | $810 |
| 2016-09-30 | $97 |
| 2016-06-30 | $516 |
| 2016-03-31 | $465 |
| 2015-12-31 | $352 |
| 2015-09-30 | $295 |
| 2015-06-30 | $137 |
| 2015-03-31 | $293 |
| 2014-12-31 | $349 |
| 2014-09-30 | $401 |
| 2014-06-30 | $446 |
| 2014-03-31 | $381 |
| 2013-12-31 | $378 |
| 2013-09-30 | $77 |
| 2013-06-30 | $405 |
| 2013-03-31 | $381 |
| 2012-12-31 | $392 |
| 2012-09-30 | $389 |
| 2012-06-30 | $449 |
| 2012-03-31 | $383 |
| 2011-12-31 | $337 |
| 2011-09-30 | $364 |
| 2011-06-30 | $447 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $43.913B | $21.840B |
| Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |